Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preclinical findings for antiangiogenic botanical IDN-5390

June 27, 2003

Once-daily dosing feasible for canertinib in advanced solid tumors

June 27, 2003

Finasteride may reduce the risk of prostate cancer

June 27, 2003

Limited antitumor activity for SU-6668 monotherapy in multiple myeloma

June 27, 2003

Gemzar/Taxol approved in Finland for metastatic breast cancer

June 27, 2003

Palonosetron phase III program reports results

June 26, 2003

AVI-4126 detected in breast and prostate tumors

June 26, 2003

Dabur scientists design novel antitumor polypeptides

June 26, 2003

Pfizer claims new KDR/FLK-1 modulators with utility in cancer and other disorders

June 26, 2003

Beneficial effects reported for satraplatin combined with prednisone in HRPC

June 26, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Neuracle eyes Shanghai IPO as global BCI funding surges
BioWorld
Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...